Skip to main content
Log in

The significance of micrographia as a clinical feature of Parkinson’s disease and underlying pathophysiology

  • Letter to the Editor
  • Published:
Neurological Sciences Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Data Availability

Data sharing is not applicable to this article as no new data were created or analyzed in this study.

Abbreviations

MMSE :

Mini-mental state examination

References

  1. AJ L (2011) A dictionary of neurological signs, in: r. edition (Ed.) Springer, New York

  2. Kim EJ, Lee BH, Park KC, Lee WY, Na DL (2005) Micrographia on free writing versus copying tasks in idiopathic Parkinson’s disease. Parkinsonism Relat Disord 11(1):57–63

    Article  PubMed  Google Scholar 

  3. Inzelberg R, Plotnik M, Harpaz NK, Flash T (2016) Micrographia, much beyond the writer’s hand. Parkinsonism Relat Disord 26:1–9

    Article  PubMed  Google Scholar 

  4. Wu T, Zhang J, Hallett M, Feng T, Hou Y, Chan P (2016) Neural correlates underlying micrographia in Parkinson’s disease. Brain 139(Pt 1):144–160

    Article  PubMed  Google Scholar 

  5. Zham P, Poosapadi SA, Kempster P, Raghav S, Nagao KJ, Wong K, Kumar D (2021) Differences in levodopa response for progressive and non-progressive micrographia in Parkinson’s disease. Front Neurol 12:665112

    Article  PubMed  PubMed Central  Google Scholar 

  6. Eklund M, Nuuttila S, Joutsa J, Jaakkola E, Makinen E, Honkanen EA, Lindholm K, Vahlberg T, Noponen T, Ihalainen T, Murtomaki K, Nojonen T, Levo R, Mertsalmi T, Scheperjans F, Kaasinen V (2022) Diagnostic value of micrographia in Parkinson’s disease: a study with [(123)I]FP-CIT SPECT. J Neural Transm (Vienna) 129(7):895–904

    Article  CAS  PubMed  Google Scholar 

  7. Ling H, Massey LA, Lees AJ, Brown P, Day BL (2012) Hypokinesia without decrement distinguishes progressive supranuclear palsy from Parkinson’s disease. Brain 135(Pt 4):1141–1153

    Article  PubMed  PubMed Central  Google Scholar 

  8. Miguelez C, De Deurwaerdere P, Sgambato V (2020) Editorial: Non-dopaminergic systems in Parkinson’s disease. Front Pharmacol 11:593822

    Article  PubMed  PubMed Central  Google Scholar 

  9. Klein JC, Eggers C, Kalbe E, Weisenbach S, Hohmann C, Vollmar S, Baudrexel S, Diederich NJ, Heiss WD, Hilker R (2010) Neurotransmitter changes in dementia with Lewy bodies and Parkinson disease dementia in vivo. Neurology 74(11):885–892

    Article  CAS  PubMed  Google Scholar 

  10. Xu Y, Yan J, Zhou P, Li J, Gao H, Xia Y, Wang Q (2012) Neurotransmitter receptors and cognitive dysfunction in Alzheimer’s disease and Parkinson’s disease. Prog Neurobiol 97(1):1–13

    Article  PubMed  PubMed Central  Google Scholar 

  11. Mallet N, Leblois A, Maurice N, Beurrier C (2019) Striatal cholinergic interneurons: how to elucidate their function in health and disease. Front Pharmacol 10:1488

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Wagle Shukla A, Ounpraseuth S, Okun MS, Gray V, Schwankhaus J, Metzer WS (2012) Micrographia and related deficits in Parkinson’s disease: a cross-sectional study. BMJ Open 2(3):e000628

  13. Lange KW, Mecklinger L, Walitza S, Becker G, Gerlach M, Naumann M, Tucha O (2006) Brain dopamine and kinematics of graphomotor functions. Hum Mov Sci 25(4–5):492–509

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Contributions

Concept – H.O.; design – H.O.; supervision – S.C.; materials – H.O, S.C.; data collection and/or processing – H.O., S.C.; analysis and/or interpretation – HO., S.C.; literature search – H.O; writing manuscript – H.O.; critical review – S.C.

Corresponding author

Correspondence to Halil Onder.

Ethics declarations

Ethical approval

Not applicable.

Informed consent

The consent form has been obtained from the patient and his spouse.

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Onder, H., Comoglu, S. The significance of micrographia as a clinical feature of Parkinson’s disease and underlying pathophysiology. Neurol Sci 44, 1791–1793 (2023). https://doi.org/10.1007/s10072-022-06590-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10072-022-06590-y

Navigation